The storied family office has also launched a new RIA, to which it will transition the vast majority of its $9 billion in ...
The Eagles are back in the Super Bowl for the second time in three seasons and we’re celebrating with one more round of The Road to Victory Bus Tour! NBC Sports Philadelphia is hitting the road ...
Pitcairn, one of America's leading family offices that has served many leading ultra-high-net-worth families for more than a century, has announced its latest initiative in its mission to provide an ...
Private market allocations are rapidly becoming a significant portion of advisors' book of business, according to a recent survey of investment advisors conducted by global private markets investment ...
Chief Commercial Officer of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a $6.79 billion market cap biopharmaceutical ...
Private markets are poised to gain market share during the coming year, according to a survey by Hamilton Lane, a global private market investment firm in Conshohocken, Pa.
What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
What does this Advisor Specialize in? Find a financial advisor who specializes in the area of expertise you require. It's important to find an advisor who can help you approach your personal and ...
William John Sibold, the President and CEO of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), has sold shares of the company worth $531,020. The transaction involved the sale of 1,584 shares at a price ...
As part of BD+C's 2025 office roundup, we categorized over 30 projects throughout various articles. Here are nine extra office projects that have been completed in the past ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
In a report released on January 27, Arun Viswanathan from RBC Capital maintained a Buy rating on Quaker Chemical (KWR – Research Report), with ...